跳至主要内容
临床试验/ITMCTR2100005305
ITMCTR2100005305尚未招募4 期

A prospective, multicenter, large sample, registry-based clinical trial design to evaluate the efficacy and safety of Angong Niuhuang Pill in the acute phase of stroke

Integrated Hospital of Traditional Chinese Medicine, Southern Medical University0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational study

入排标准

性别
All

入选标准

  • 1. The subject was clinically diagnosed with acute stage of stroke and the responsible lesion (infarct or hemorrhage foci) appeared on imaging, and the subject was prescribed Angong Niuhuang Pills for more than 3 days.
  • 2. The Chinese medicine diagnosis is phlegm-heat internal closure evidence
  • 3. Subjects voluntarily enrolled in this study and signed a written informed consent form.

排除标准

  • 1. Patients with stroke caused by brain tumor, traumatic brain injury, hematological disease, rheumatic heart disease, coronary heart disease and other heart disease combined with atrial fibrillation.
  • 2. Other patients who are considered by the investigator to be inappropriate for participation in this study.

研究者

发起方
Integrated Hospital of Traditional Chinese Medicine, Southern Medical University

相似试验